Sky News Veteran Dermot Murnaghan Reveals Advanced Prostate Cancer Diagnosis

**Veteran Broadcaster Dermot Murnaghan Reveals Stage Four Prostate Cancer Diagnosis**
Cardiff News Online Article Image

Traffic Updates
Dermot Murnaghan, a renowned British journalist and presenter, has revealed that he is currently battling stage four prostate cancer. Murnaghan, who left Sky News in 2023 after more than 15 years at the channel, shared the news in a candid message posted on social media, prompting a wave of support from family, colleagues and viewers alike.

Announcing his diagnosis on X (formerly Twitter) on Monday, the 67-year-old broadcaster emphasised that he remains “in good spirits” and is responding well to treatment. “Some personal news… I’ve been diagnosed with Stage IV advanced prostate cancer,” Murnaghan wrote. He praised his healthcare team, highlighting both their medical expertise and their compassion. “I’m fortunate to have a simply outstanding medical team looking after me, who I can’t thank enough – they are administering the best possible care with expertise, compassion and sensitivity,” he added.

Traffic Updates
Stage four prostate cancer is a serious diagnosis, often indicating that the disease has extended beyond the prostate gland to other parts of the body. According to Cancer Research UK, it can spread to the bones, liver, lungs, and lymph nodes, or even infiltrate neighbouring organs such as the bladder. Despite the challenges posed by the illness, Murnaghan’s message carried a tone of resilience; he noted: “I’m responding positively to their excellent treatment, and feeling well.”

He also acknowledged the emotional support that has helped him in recent weeks, expressing gratitude not only for his immediate family, but also for the wider circle of friends and supporters who have rallied around him. “I’m blessed to be fortified by the monumental love and support of my wife, family and close friends,” he shared in his update.

Taking a proactive approach, the former news anchor called upon men—particularly those over 50 or at increased risk—to seek regular medical screening and advocate for routine checks on the NHS. “Needless to say, my message to all men over 50, in high risk groups, or displaying symptoms, is get yourself tested and campaign for routine prostate screening by the NHS,” Murnaghan urged. His statement reflects ongoing discussions around early detection and public health.

Demonstrating characteristic determination, Murnaghan also revealed his intention to participate in a charity cycling event later this year. He hopes to join six-time Olympic champion Sir Chris Hoy in a charity ride this September, raising money and awareness for cancer charities across the UK. Hoy himself publicised his terminal diagnosis with prostate cancer in October 2024, and the upcoming “Tour de 4” event seeks to challenge perceptions about those living with advanced forms of cancer. The ride is scheduled to start and finish at Glasgow’s Sir Chris Hoy Velodrome, with the aim of encouraging more men to take proactive steps regarding their health.

Statistics from Prostate Cancer UK suggest that about one in eight men will receive a prostate cancer diagnosis in their lifetime, with many experiencing few or no symptoms in the condition’s early stages—a fact underscoring the importance of Murnaghan’s message.

Murnaghan’s career, which spans several decades, has seen him present some of Britain’s most prominent news programmes, including ITV’s News at Ten, the BBC’s Ten O’Clock News, and Channel 4 News. He also hosted the long-running BBC quiz show Eggheads, as well as leading news coverage of significant events such as the passing of Queen Elizabeth II and the 2019 general election.

The news of his illness has been met with well-wishes from across the broadcasting community and beyond, with many praising his openness about his condition and his advocacy for public awareness. For many, Murnaghan’s story is both a reminder of the challenges posed by prostate cancer and an inspiration to remain vigilant with one’s health.